Asthma News and Research

RSS

Asthma is a common inflammatory disease affecting the airways that leads to shortness of breath, coughing and wheezing. Symptoms range from mild to severe but are generally manageable with appropriate treatment.

Centocor Ortho Biotech acquires RespiVert

Centocor Ortho Biotech Inc. today announced that it has acquired RespiVert Ltd., a privately held drug discovery company focused on developing small-molecule, inhaled therapies for the treatment of pulmonary diseases. The company's lead compounds, RV-568 and RV-1088, narrow spectrum kinase inhibitors with a unique profile of anti-inflammatory activities, are progressing into clinical development as potential first-in-class treatments for moderate to severe asthma, Chronic Obstructive Pulmonary Disease (COPD) and Cystic Fibrosis (CF).

1 Jun 2010

Allergic reactions prevent people with allergic asthma from generating healthy immune response to influenza

New research from UT Southwestern Medical Center suggests that allergic reactions to pet dander, dust mites and mold may prevent people with allergic asthma from generating a healthy immune response to respiratory viruses such as influenza.

29 May 2010

One-quarter of all hospital patients experience readmission for same conditions: AHRQ

Roughly one-quarter of all hospital patients were readmitted over a two-year period for the same conditions that prompted their initial hospitalization, according to the latest News and Numbers by the Agency for Healthcare Research and Quality.

28 May 2010

Weill Cornell Medical College commences construction of 18-story, $650 million Medical Research Building

Weill Cornell Medical College today celebrated the start of construction on its new Medical Research Building, a state-of-the-art facility that will more than double the institution's existing research space. The 18-story, $650 million building is the centerpiece of Weill Cornell's $1.3 billion Discoveries that Make a Difference Campaign, the country's largest for a medical college. A total of $1 billion has been raised toward this goal in a record time of less than four years.

27 May 2010

Amira announces UK patent grant for heteroalkyl antagonists of prostaglandin D2 receptors

Amira Pharmaceuticals, Inc. today announced that the U.K. Intellectual Property Office has granted patent number GB2461629, titled, "HETEROALKYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS," which includes coverage of Amira's AM461 DP2 receptor antagonist.

27 May 2010

POZEN receives milestone payment from AstraZeneca for FDA approval of VIMOVO

POZEN Inc., announced today the receipt of a $20 million milestone payment from AstraZeneca for the U.S. Food and Drug Administration approval of VIMOVO (naproxen and esomeprazole magnesium) delayed-release tablets on April 30th. POZEN will transfer ownership of the Investigational New Drug application and New Drug Application for VIMOVO to AstraZeneca over the next few weeks.

26 May 2010

Research findings on pediatric ILD published online in PED

An insightful and in-depth presentation of the most up-to-date clinical and research findings and historical perspectives on pediatric interstitial lung disease is presented in a special issue published online ahead of print in Pediatric Allergy, Immunology, and Pulmonology, a peer-reviewed journal published by Mary Ann Liebert, Inc.

26 May 2010

WIN for Asthma program improves outcomes for children with poorly controlled asthma

With childhood asthma rates in Northern Manhattan four times the national average, the Ambulatory Care Network at NewYork-Presbyterian Hospital partnered with the community of Washington Heights/Inwood to initiate the Washington-Heights Inwood Network for Asthma program. The program began in May 2006 to improve outcomes for children with poorly controlled asthma by providing culturally relevant asthma education. To date, Community Health Workers have enrolled 400 families.

25 May 2010

New FDA approved Landon Medical LM-800 Finger Pulse Oximeter available for home use

PulseOximetersDIRECT.com, the leading online retailer of portable Pulse Oximeter products introduces today the new, affordable $39 FDA approved Landon Medical LM-800 Finger Pulse Oximeter for home use.

24 May 2010

New marker may be the significant breakthrough in allergy testing for newborn babies

A simple blood test can now predict whether newborn babies are at high risk of developing allergies as they grow older, thanks to research involving the University of Adelaide.

21 May 2010

Ligand Pharmaceuticals secures milestone and royalty interest in IL-9 antibody program

Ligand Pharmaceuticals Incorporated announced today that it has purchased from the Genaera Liquidating Trust certain intellectual property and interests in future milestones and royalties for MEDI-528, an IL-9 antibody program under development by AstraZeneca's subsidiary, MedImmune. MEDI-528 is currently in a 320-patient Phase II study for moderate-to-severe asthma.

21 May 2010

New drug testing technique is safe and effective

A new study from the Swedish medical university Karolinska Institutet presents a new technique that makes drug testing possible through exhaled air for the first time.

21 May 2010

Arizona's smoking ban reduces hospital admissions for stroke, asthma and angina

Two University of Arizona researchers have studied the relationship between Arizona's 2007 law that bans smoking in public places and hospitalization rates for a range of ailments related to secondhand smoke exposure.

21 May 2010

American Legion testifies in Congress on bills affecting veterans

The American Legion testified in Congress yesterday on several pieces of pending legislation that would affect veterans if signed into law.

20 May 2010

Ectoin shows positive effect on nanoparticle-induced lung inflammation: Study

bitop AG, which specializes in the development and marketing of Ectoin-containing medical devices, announces that Ectoin significantly reduces nanoparticle-induced inflammatory reaction in rat lungs, one of the animal models for chronic obstructive pulmonary disease. It is the first time that Ectoin has been shown to have such an effect on nanoparticle-induced lung inflammation.

20 May 2010

Allergy sufferers can save out-of-pocket costs by visiting urgent care and retail health clinics instead of ER

In this economy, allergy sufferers are looking for relief from more than sneezing, runny noses, and itchy eyes. And, according to a recent study, they can find relief for both their symptoms and their wallets, saving anywhere from $50 to $400 in out-of-pocket costs per visit if they skip the emergency room and head to urgent care and retail health clinics when they are unable to see their primary physician.

20 May 2010

Drug trend for children increased 10.8% in 2009 across America

In growing numbers, children across America are adding a dose of medicine to their daily routine. In 2009, drug trend for children – a measure of prescription spending growth – increased 10.8 percent, driven by a 5 percent increase in drug utilization and higher medication costs, according to the Medco 2010 Drug Trend Report. The growth in prescription drug use among children was nearly four times higher than the rise seen in the overall population.

20 May 2010

NPMA: Cockroach allergens can trigger allergies, asthma attacks

In recognition of National Allergy and Asthma Awareness Month, celebrated each May, the National Pest Management Association is reminding families that cockroach allergens can trigger allergies and asthma attacks. The saliva, droppings and decomposing bodies of cockroaches contain allergen proteins known to trigger allergies and increase the severity of asthma symptoms, especially in children.

20 May 2010

AIR Trial demonstrates benefits of BT in asthma patients

Asthmatx Inc., today presented positive five-year data from the Asthma Intervention Research Trial, which evaluated the safety of bronchial thermoplasty with the Alair System. The data demonstrated the absence of clinical complications and the maintenance of stable lung function over a five year period post-BT in patients with moderate to severe asthma.

20 May 2010

Rising number of asthma deaths in Australia: Study

According to a study by the Australian Institute of Health and Welfare the number of people over 45 dying from asthma attacks has increased in the past five years. In 2006 402 people had died of asthma. 2005 had only 318 deaths related to asthma in comparison. 2006 saw a 40 percent hike from the preceding three years says the report.

19 May 2010

Asthma News and Research

Further Reading

Centocor Ortho Biotech acquires RespiVert

Allergic reactions prevent people with allergic asthma from generating healthy immune response to influenza

One-quarter of all hospital patients experience readmission for same conditions: AHRQ

Weill Cornell Medical College commences construction of 18-story, $650 million Medical Research Building

Amira announces UK patent grant for heteroalkyl antagonists of prostaglandin D2 receptors

POZEN receives milestone payment from AstraZeneca for FDA approval of VIMOVO

Research findings on pediatric ILD published online in PED

WIN for Asthma program improves outcomes for children with poorly controlled asthma

New FDA approved Landon Medical LM-800 Finger Pulse Oximeter available for home use

New marker may be the significant breakthrough in allergy testing for newborn babies

Ligand Pharmaceuticals secures milestone and royalty interest in IL-9 antibody program

New drug testing technique is safe and effective

Arizona's smoking ban reduces hospital admissions for stroke, asthma and angina

American Legion testifies in Congress on bills affecting veterans

Ectoin shows positive effect on nanoparticle-induced lung inflammation: Study

Allergy sufferers can save out-of-pocket costs by visiting urgent care and retail health clinics instead of ER

Drug trend for children increased 10.8% in 2009 across America

NPMA: Cockroach allergens can trigger allergies, asthma attacks

AIR Trial demonstrates benefits of BT in asthma patients

Rising number of asthma deaths in Australia: Study

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News